Found 37 matching trials
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC PHASE2 RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Show More Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Learn More & Join Trial
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD PHASE2 Study aims at evaluating the therapeutic efficacy and safety of low-dose IL...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Biological Therapy in Treating Women With Stage IV Breast Cancer PHASE1 RATIONALE: Biological therapies use different ways to stimulate the immune ...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Dendritic Cell Based Therapy of Malignant Melanoma PHASE1 The aim of the study is to show if vaccination with autologous dendritic ce...
Show More Location
Department of Oncology, Copenhagen University Hospital, Herlev
Learn More & Join Trial
IL-2 for Multi Drug Resistant Nephrotic Syndrome PHASE1 The aim of the study is to design an open-label phase 1-2 trial to assess s...
Show More Location
Istituto Giannina Gaslini
Learn More & Join Trial
T-cell Based Immunotherapy for Head and Neck Cancer PHASE1 The aim of this study is to investigate the toxicity and immune response of...
Show More Location
Department of Oncology, Copenhagen University Hospital, Herlev
Learn More & Join Trial
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata PHASE1 Alopecia areata is an autoimmune disease associated with infiltration of cl...
Show More Location
CHU de Nice - Hôpital Archet
Learn More & Join Trial
Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients PHASE1 To improve the efficacy of immunotherapy for cancer, recent studies focused...
Show More Location
Nantes University Hospital
Learn More & Join Trial
T-cell Based Immunotherapy for of Melanoma PHASE1 The aim of this study is to investigate the toxicity and clinical response ...
Show More Location
Department of Oncology, Copenhagen University Hospital, Herlev
Learn More & Join Trial